If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than ...

If you’re dealing with male pattern baldness, there’s a good chance you’ve heard of or use finasteride. You also may have ...

This is a story that really connects with men. We can understand how Esau felt after he came in from a long day in the fields. He had been hunting, and he was tired, hot and famished. Hunger consumed ...

Priapism is a non-intimate prolonged arousal that isn’t relieved by climax. It is a serious medical emergency that can cause ...

Convenience is the name of the game here — and it's why so many men turn to Hims to resolve their hair loss concerns, along with the fact that there are so many options formulated for different ...

SHOPPING: If you're done dealing with thinning hair, a receding hairline, and a lack of confidence, it's time to reverse the ...

Hims & Hers Health is a telehealth company known for offering compounded alternatives to popular GLP-1 weight-loss treatments. Its shares have soared over 120% since August 2023. Also Read ...

Service Appreciation Initiative to increase access to safe and affordable weight loss treatment SAN FRANCISCO, September 18, 2024--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers", NYSE ...

U.S. telehealth company Hims & Hers Health said it will sell compounded versions of Novo Nordisk’s popular weight-loss drug Wegovy to patients in certain professions for $99 a month.

NEW YORK, Sept 18 (Reuters) - U.S. telehealth company Hims & Hers Health (HIMS.N), opens new tab on Wednesday said it will sell compounded versions of Novo Nordisk's (NOVOb.CO), opens new tab ...

Hims & Hers' stock decline after GLP-1 concerns is an overreaction, presenting a strong investment opportunity. Management's consistent outperformance and strategic leadership, including key hires ...